Every Cure
Lee Lancashire currently serves as the Head of Data Science at Every Cure, focusing on leveraging advanced AI to identify drug repurposing opportunities for various diseases. With extensive experience in the field, Lee has held prominent positions such as Chief Information Officer and Chief Data and AI Officer at Cohen Veterans Bioscience, where responsibility encompassed strategic directions for data analytics. Lee's career also includes roles as a Principal Research Scientist at Thomson Reuters, Bioinformatics Manager at CompanDx Ltd, and a Postdoctoral Researcher at Cancer Research UK Manchester Institute, among others. Education includes a PhD in the Development of Artificial Neural Network algorithms applied to Bioinformatics from Nottingham Trent University, complemented by a Master’s in Applied Molecular Microbiology and a Bachelor's in Biotechnology. Lee is also a dedicated member of the Board of Trustees and Treasurer for the Ichthyosis Support Group, supporting families affected by rare skin disorders.
This person is not in any teams
This person is not in any offices
Every Cure
1 followers
Every Cure is a nonprofit organization dedicated to unlocking the full potential of every existing medicine to treat every disease possible. Repurposing existing drugs is the fastest and most efficient way to treat diseases with the greatest return on investment for saving lives. However, systemic barriers impede repurposing, so patients suffer while potential treatments are not fully utilized. Every Cure overcomes these barriers to systematically identify and advance promising repurposing opportunities and save lives. Every Cure is taking a revolutionary and disruptive approach to overcome these systemic barriers by developing a comprehensive, open-source data engine to generate predictive efficacy scores for all 3,000 drugs against all 12,000 diseases and rapidly advance treatments to patients. In partnership with academia, industry, and government, Every Cure is integrating proprietary and public data into a comprehensive dataset, optimizing AI ranking algorithms, validating the most promising drug-disease matches, performing trials, and ensuring patient access to effective therapies.